Lei L. Li

Key Laboratory Of Environment And Genes Related To Diseases
Xi'an, 710061, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 154 publications

Corrigendum to "DAB2IP regulates the chemoresistance to pirarubicin and tumor recurrence of non-muscle invasive bladder cancer through STAT3/Twist1/P-glycoprotein signaling" [Cellular Signaling, 2015 Sep 26; 27(12): 2515-2523].

Corrigendum to "DAB2IP regulates the chemoresistance to pirarubicin and tumor recurrence of non-muscle invasive bladder cancer through STAT3/Twist1/P-glycoprotein signaling" [Cellular Signaling, 2015 Sep 26; 27(12): 2515-2523].

Journal: Cellular signalling

Published: July 14, 2026

Loss of CYLD on Chromosome 16q Impairs Homologous Recombination and Genomic Stability Through TIRR Degradation.

Loss of CYLD on Chromosome 16q Impairs Homologous Recombination and Genomic Stability Through TIRR Degradation.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: May 13, 2026

Integrated bulk and single-cell transcriptomics reveals TREH as a novel protective biomarker and prognostic predictor in clear cell renal cell carcinoma.

Integrated bulk and single-cell transcriptomics reveals TREH as a novel protective biomarker and prognostic predictor in clear cell renal cell carcinoma.

Journal: Frontiers in oncology

Published: February 10, 2026

Niraparib With Abiraterone Acetate Plus Prednisone as First-Line Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer With Homologous Recombination Repair Gene Alterations: Final Analysis of the Asian Subgroup From the MAGNITUDE Study.

Niraparib With Abiraterone Acetate Plus Prednisone as First-Line Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer With Homologous Recombination Repair Gene Alterations: Final Analysis of the Asian Subgroup From the MAGNITUDE Study.

Journal: International journal of urology : official journal of the Japanese Urological Association

Published: December 18, 2025

USP20 governs tyrosine kinase inhibitors resistance through ferroptosis evasion by targeting GPX4 in cancers.

USP20 governs tyrosine kinase inhibitors resistance through ferroptosis evasion by targeting GPX4 in cancers.

Journal: Redox biology

Published: December 09, 2025

Single-nucleus RNA sequencing reveals the cellular composition and the mechanism underlying adrenal myelolipoma.

Single-nucleus RNA sequencing reveals the cellular composition and the mechanism underlying adrenal myelolipoma.

Journal: Endocrine

Published: December 05, 2025

RGS19 drives tumor progression and immunosuppression in clear cell renal cell carcinoma by modulating CAMs and EMT.

RGS19 drives tumor progression and immunosuppression in clear cell renal cell carcinoma by modulating CAMs and EMT.

Journal: World journal of surgical oncology

Published: November 24, 2025

Multi-stimuli activated PROTAC prodrug for controlled protein degradation with enhanced therapeutic effects.

Multi-stimuli activated PROTAC prodrug for controlled protein degradation with enhanced therapeutic effects.

Journal: European journal of medicinal chemistry

Published: August 22, 2025

RAD51-targeting small molecule degrader sensitizes BRCA-proficient prostate cancer cells to PARP inhibitors via synthetic lethality.

RAD51-targeting small molecule degrader sensitizes BRCA-proficient prostate cancer cells to PARP inhibitors via synthetic lethality.

Journal: Acta pharmaceutica Sinica. B

Published: August 04, 2025

NuRD-enabled CTCF-TET crosstalk orchestrates epigenome reprogramming and genome architecture.

NuRD-enabled CTCF-TET crosstalk orchestrates epigenome reprogramming and genome architecture.

Journal: Molecular cell

Published: June 04, 2025

Hypoxia-responsive Exatecan prodrug liposomes co-delivered with IR808 for synergistic chemo-photodynamic therapy of breast cancer.

Hypoxia-responsive Exatecan prodrug liposomes co-delivered with IR808 for synergistic chemo-photodynamic therapy of breast cancer.

Journal: International journal of pharmaceutics: X

Published: May 18, 2025

PTTG1-mediated reprogramming of asparagine metabolism enhances DNA damage repair and leads to compromised antitumor immunity in prostate cancer.

PTTG1-mediated reprogramming of asparagine metabolism enhances DNA damage repair and leads to compromised antitumor immunity in prostate cancer.

Journal: Urologic oncology

Published: May 12, 2025

Showing 1-12 of 154

Last Updated: 09/26/2026